SCHEMBL6527496

SCHEMBL6527496

CC(OC1CC[CH]CC1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 3/20 0.45
DRD3 P35462 3/20 0.45
CHRM2 P08172 2/20 0.45
CHRM1 P11229 2/20 0.45
DRD1 P21728 2/20 0.45
SLC6A2 P23975 2/20 0.45
ADRA1A P35348 2/20 0.45
OPRM1 P35372 2/20 0.45
SLC6A3 Q01959 2/20 0.45
KCNH2 Q12809 2/20 0.45
CYP2D6 P10635 2/20 0.45
HTR1A P08908 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
MAPK1 P28482 1/20 0.44
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
DRD2 P14416 2/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7458156 0.89 CHRM2 (0.47) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL7455239 0.87 CHRM2 (0.46) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL873248 0.87 CHRM2 (0.46) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL3130007 0.80 HRH1 (0.50) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL5011303 0.80 KCNH2 (0.44) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL29117311 0.80 HRH1 (0.50) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL18469978 0.79 CHRM1 (0.73) ADRA2ADRD3CHRM2CHRM1DRD1
Hydrochloric Acid SCHEMBL18428982 0.79 HRH1 (0.49) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL12093070 0.76 DRD3 (0.46) ADRA2ADRD3CHRM2CHRM1DRD1
SCHEMBL17704575 0.74 DRD2 (0.73) ADRA2ADRD3CHRM2CHRM1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019222-A1 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2005-03-03 WO disclosed